Form 8-K - Current report:
SEC Accession No. 0001193125-20-278634
Filing Date
2020-10-27
Accepted
2020-10-27 17:29:00
Documents
7
Period of Report
2020-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d85208d8k.htm 8-K 35621
2 EX-1.1 d85208dex11.htm EX-1.1 150310
3 EX-4.1 d85208dex41.htm EX-4.1 91577
4 EX-4.2 d85208dex42.htm EX-4.2 91111
5 EX-4.3 d85208dex43.htm EX-4.3 93825
6 EX-10.1 d85208dex101.htm EX-10.1 177650
7 EX-99.1 d85208dex991.htm EX-99.1 9710
  Complete submission text file 0001193125-20-278634.txt   651096
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 201265261
SIC: 2834 Pharmaceutical Preparations